Research Xchange Forum 2018

Insights | Translation | Solutions
Trends and Challenges in Regenerative Medicine and Cell Therapy 

March 20-21, 2018
Sartorius College
Goettingen, Germany
Save to your calendar

Our Research Xchange Forum brings together experts from academia and industry to foster the exchange of ideas and to stimulate dialog about the next generation of interdisciplinary research. Join our discussions and listen to keynote lectures by leading international biopharma R&D experts. Further highlights: The winner and the finalists of "The Sartorius & Science Prize for Regenerative Medicine & Cell Therapy 2018" will present the results of their research.

Who Should Attend

This forum is ideal for professionals of these areas:

  • Pharmaceutical and biopharmaceutical companies
  • Universities and research institutes
  • Contract services and research laboratories
  • Government testing agencies

6 Reasons Why You Need to Be a Part of This Xchange

1. Gain insights into the latest findings

  • Keynote lectures on cellular immunotherapy by industry experts
  • Lectures from academic experts on the latest developments 

2. Meet the winner and finalists of the "Sartorius & Science Prize"

  • Lectures to be held by the winner and the 3 finalists of “The Sartorius & Science Prize for Regenertaive Medicine & Cell Therapy
  • Speech by Science editor Dr. Priscilla N. Kelly  
  • Gala dinner and awards ceremony for exceptional scientists

3. Join our discussions and meet partners for potential collaboration

  • Panel discussion with stakeholders from industry and academia, including Science editor Dr. Priscilla N. Kelly  
  • Thought-provoking dialog and networking opportunities with like-minded companies and academic professionals to gain a better understanding of their workflows and challenges

4. See our exhibition on applications in regenerative medicine and cell therapy

  • Sartorius experts will talk about applications and how to improve workflows 

5. Gain exclusive insights during a tour through our manufacturing plant

  • Take the opportunity to experience Sartorius from the inside.
  • Learn how we manufacture and manage our workflows in the real world.

6. Be a part of social media live reporting and become a trendsetter


  • Ask questions that stick in your mind
  • Share topics and new findings meaningfully and sustainably and show which ones are important for you 

Speaker Line-Up

Keynote Lecture by the Winner and Lectures by the 3 Finalists of "The Sartorius & Science Prize for Regenerative Medicine & Cell Therapy 2018"

Dr. Priscilla N. Kelly,
Washington DC, USA


Editor for biomedicine

Topic: "How to publish in Science"


Prof. Dr. Stefan W. Hell,
Goettingen, Germany

Max Planck Institute for Biophysical Chemistry

Managing Director Max Planck Institute for Biophysical Chemistry

Nobel laureate of 2014 in chemistry 

*© Peter Badge/Typos1 in cop. with Foundation Lindau Nobel Laureate Meetings
all rights reserved 2017.

Dr. Ulf Geumann,
Munich, Germany

apceth Biopharma GmbH
Group leader Preclinical Development

Topic: Mesenchymal stem cells in immunotherapy

Overview: apceth is harnessing the potential of mesenchymal stem cells (MSC), in which the mechanism of therapeutic effects are very different from that of CAR-T cells. The aim is to provide innovative cell-based gene therapies for the treatment of major indications such as cancer, chronic lung and kidney diseases and for immunomodulation. 

apceth has created its allogenic therapeutic platform based entirely on the genetic engineering of MSC isolated from healthy donors. 

Francesca Bellintani,
Milan, Italy

Vector Downstream Process Development Manager

Topic: Retroviral and lentiviral production: development and scaling up of upstream and downstream process steps

Overview: MolMed has implemented a large-scale process to meet the increasing demand for clinical and commercial grade vector production. There is a special focus on identification of challenges in the downstream/purification strategy to ensure efficient contaminant removal and preservation of viral infectivity.

Dr. Thierry Wurch,
Suresnes, France

Director of External Studies in Immuno-oncology

Topic: Allogenic approach developed by Servier and the preclinical data of UCART19

Overview: Servier is applying the Cellectis’ TALEN gene editing technology to overcome current limitations and provide an allogeneic, frozen, “off-the-shelf” T cell based medicinal product.

UCART19 is an allogeneic CAR T-cell product candidate being developed for treatment of CD19-expressing hematological malignancies. It is currently being evaluated in a phase 1 clinical trials in relapsed/refractory acute lymphoblastic leukemia (ALL) of adult and pediatric patients. The selection of UCART19 as a candidate was based on the impressive clinical benefits leading to the marketing of the two first autologous CAR T-cell products Kymriah (Novartis) and Yescarta (Kite Gilead). 

Dr. Nina G. Bauer,
Basel, Switzerland

Assoc. Director of Commercial Development, Autologous Cell Therapies

Topic: Manufacturing strategies for patient scale cell therapies

Overview: The “Future Technologies” business area under the Pharma & Biotech division of Lonza has a focus on personalized medicine & cell therapy. One of the major challenges in these fields is the production of the patient-specific and patient-scale CAR-T cells or stem cells for treatment. 

Lonza has partnered with Octane on the Octane CocoonTM platform, which offers a ground-breaking innovation to address this challenge. Unlike current, labor-intensive production methods, this platform has the potential to enable the automated manufacturing of patient-specific cell therapies for maximum efficiency, traceability and scale-up. 

Lectures from “The Sartorius & Science Prize for Regenerative Medicine & Cell Therapy” Winner and Finalists.


How to Get There

Conference address

Sartorius College
Otto-Brenner-Str. 20
37079 Goettingen, Germany

Phone +49-551-308-2101

On the A7 freeway (Hannover- Kassel), take the exit bound for Goettingen Nord (72). Then take the first exit to Industriegebiet (industrial zone) and afterwards, the first exit in the traffic circle. At the next light, make a left turn. Sartorius College will be on your left-hand side.

The nearest airports are Hanover, Kassel and Frankfurt in Germany. From there, you can reach Goettingen by train or car. By taxi, it will take about 10 minutes to get from the Goettingen train station to Sartorius College.

We have arranged for a limited number of accommodations under special conditions at the hotel listed below.

Park Inn by Radisson Goettingen
Kasseler Landstraße 25C
37081 Goettingen, Germany

Phone +49-551-2707070


Impressions of Research Xchange Forum 2017

Trends and Challenges in Oncology

Our first Research Xchange Forum about trends and challenges in oncology took place in February 2017. Lectures given by 12 internationally renowned academics and leading biopharma R&D executives provided insights into the latest developments of their specific cancer research and therapy approaches. At this event, we also focused exchanging ideas and enhancing collaboration between academia and industry. This also included a lively panel discussion covering controversial opinions. 


Get impressions: review of the 2-day Forum


Ticket Prices

We offer an early bird discount up to January 15, 2018.

The registration fee includes admission, gala dinner, all coffee breaks, lunches and the optional plant tour. Advance registration is required.

Academia  Postdocs/ PhD Students/
Early Bird395 EUR*295 EUR*105 EUR*
Regular595 EUR*495 EUR*195 EUR*
Group TicketPay for the 1st ticket and get 50% off on every additional registration

*All prices are excluding VAT



Your Data


Any Further Questions?

If you should have any questions, do not hesitate to contact us at any time. We would be pleased to help you.

Romi Jeromis 
Sartorius Lab Instruments GmbH & Co. KG 
Phone: +49-551-308-2659